Critical role of prohibitin in endothelial cell apoptosis caused by glycated low-density lipoproteins and protective effects of grape seed procyanidin B2

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 1, 2015, Pages 13-21

  Yin, Wenbin ^a   Li, Baoying ^a   Li, Xiaoli ^a   Yu, Fei ^a   Cai, Qian ^a   Zhang, Zhen ^a   Wang, Junfu ^b   Zhang, Jianhua ^b   Zhou, Ruihai ^c   Cheng, Mei ^a   Gao, Haiqing ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; glycated low density lipoproteins; grape seed procyanidin B2; human umbilical vein endothelial cells; prohibitin

Indexed keywords

CASPASE 3; CYTOCHROME C; GRAPE SEED PROCYANIDIN B2; LOW DENSITY LIPOPROTEIN; PROCYANIDIN; PROHIBITIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BIFLAVONOID; CATECHIN; GRAPE SEED EXTRACT; PROANTHOCYANIDIN; PROCYANIDIN B2; REPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

APOPTOSIS; BIFLAVONOIDS; CATECHIN; CELL SURVIVAL; GENE EXPRESSION REGULATION; GRAPE SEED EXTRACT; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MITOCHONDRIA; PHOSPHORYLATION; PROANTHOCYANIDINS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING;

EID: 84925500489     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000157     Document Type: Article

References (48)

1. Cull CA, Jensen CC, Retnakaran R, et al. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78. Circulation. 2007;116:2119-2126.
2. Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33: 264-269.
3. Simionescu M, Popov D, Sima A, et al. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster. Am J Pathol. 1996;148: 997-1014.
4. Cohen MP, Ziyadeh FN, Chen S. Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J Lab Clin Med. 2006;147:211-219.
5. Shiu SW, Tan KC, Wong Y, et al. Glycoxidized LDL increases lectinlike oxidized low density lipoprotein receptor-1 in diabetes mellitus. Atherosclerosis. 2009;203:522-527.
6. Lorenzi M, Cagliero E, Markey B, et al. Interaction of human endothelial cells with elevated glucose concentrations and native and glycosylated low density lipoproteins. Diabetologia. 1984;26: 218-222.
7. Posch K, Simecek S, Wascher TC, et al. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes. 1999;48:1331-1337.
8. Sangle GV, Zhao R, Mizuno TM, et al. Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology. 2010;151: 4455-4466.
9. Zhao R, Shen GX. Involvement of heat shock factor-1 in glycated LDLinduced upregulation of plasminogen activator inhibitor-1 in vascular endothelial cells. Diabetes. 2007;56:1436-1444.
10. Sanchez-Quesada JL, Benitez S, Perez A, et al. The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity. Diabetologia. 2005;48:2162-2169.
11. Brown BE, Dean RT, Davies MJ. Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells. Diabetologia. 2005;48:361-369.
12. Kim Y, Choi Y, Ham H, et al. Antioxidant and cytoprotective effects of oligomeric and polymeric procyanidin fractions from defatted grape in PC12 cells. J Med Food. 2012;15:490-494.
13. Agarwal C, Veluri R, Kaur M, et al. Fractionation of high molecular weight tannins in grape seed extract and identification of procyanidin B2-3,30-di-O-gallate as a major active constituent causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells. Carcinogenesis. 2007;28:1478-1484.
14. Inaba H, Nagaoka Y, Kushima Y, et al. Comparative examination of antiproliferative activities of (-)-epigallocatechin gallate and (-)-epigallocatechin against HCT116 colorectal carcinoma cells. Biol Pharm Bull. 2008;31:79-84.
15. Ito H, Kobayashi E, Li SH, et al. Antitumor activity of compounds isolated from leaves of Eriobotrya japonica. J Agric Food Chem. 2002;50:2400-2403.
16. Li BY, Li XL, Cai Q, et al. Induction of lactadherin mediates the apoptosis of endothelial cells in response to advanced glycation end products and protective effects of grape seed procyanidin B2 and resveratrol. Apoptosis. 2011;16:732-745.
17. Li BY, Li XL, Gao HQ, et al. Grape seed procyanidin B2 inhibits advanced glycation end product-induced endothelial cell apoptosis through regulating GSK3b phosphorylation. Cell Biol Int. 2011;35: 663-669.
18. Yu F, Li BY, Li XL, et al. Proteomic analysis of aorta and protective effects of grape seed procyanidin B2 in db/db mice reveal a critical role of milk fat globule epidermal growth factor-8 in diabetic arterial damage. PLoS One. 2012;7:e52541.
19. Roskams AJ, Friedman V, Wood CM, et al. Cell cycle activity and expression of prohibitin mRNA. J Cell Physiol. 1993;157: 289-295.
20. Chowdhury I, Xu W, Stiles JK, et al. Apoptosis of rat granulosa cells after staurosporine and serum withdrawal is suppressed by adenovirus-directed overexpression of prohibitin. Endocrinology. 2007;148:206-217.
21. Coates PJ, Nenutil R, McGregor A, et al. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res. 2001;265:262-273.
22. Zhang Y, He L, Zhou Y. Taspine isolated from Radix et Rhizoma Leonticis inhibits growth of human umbilical vein endothelial cell (HUVEC) by inducing its apoptosis. Phytomedicine. 2008;15:112-119.
23. Bartnik M, Norhammar A, Ryden L. Hyperglycaemia and cardiovascular disease. J Intern Med. 2007;262:145-156.
24. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol. 1993;71:26B-31B.
25. King GL. The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Ann Med. 1996;28:427-432.
26. Graier WF, Kostner GM. Glycated low-density lipoprotein and atherogenesis: the missing link between diabetes mellitus and hypercholesterolaemia? Eur J Clin Invest. 1997;27:457-459.
27. Mishra S, Murphy LC, Murphy LJ. The prohibitins: emerging roles in diverse functions. J Cell Mol Med. 2006;10:353-363.
28. Artal-Sanz M, Tavernarakis N. Prohibitin and mitochondrial biology. Trends Endocrinol Metab. 2009;20:394-401.
29. Ren HZ, Wang JS, Wang P, et al. Increased expression of prohibitin and its relationship with poor prognosis in esophageal squamous cell carcinoma. Pathol Oncol Res. 2010;16:515-522.
30. Sato T, Sakamoto T, Takita K, et al. The human prohibitin (PHB) gene family and its somatic mutations in human tumors. Genomics. 1993;17: 762-764.
31. Wu TF, Wu H, Wang YW, et al. Prohibitin in the pathogenesis of transitional cell bladder cancer. Anticancer Res. 2007;27:895-900.
32. Gregory-Bass RC, Olatinwo M, Xu W, et al. Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis. Int J Cancer. 2008;122:1923-1930.
33. Okudan N, Bariskaner H, Gokbel H, et al. The effect of supplementation of grape seed proanthocyanidin extract on vascular dysfunction in experimental diabetes. J Med Food. 2011;14:1298-1302.
34. Theiss AL, Idell RD, Srinivasan S, et al. Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J. 2007;21: 197-206.
35. Zhou TB, Qin YH, Lei FY, et al. Association of prohibitin-1 and 2 with oxidative stress in rats with renal interstitial fibrosis. Mol Biol Rep. 2014; 41:3033-3043.
36. Oz HS, Chen TS, McClain CJ, et al. Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem. 2005;16:297-304.
37. Sripathi SR, He W, Atkinson CL, et al. Mitochondrial-nuclear communication by prohibitin shuttling under oxidative stress. Biochemistry. 2011;50:8342-8351.
38. Houde V, Grenier D, Chandad F. Protective effects of grape seed proanthocyanidins against oxidative stress induced by lipopolysaccharides of periodontopathogens. J Periodontol. 2006;77:1371-1379.
39. Xie X, Zhao R, Shen GX. Impact of cyanidin-3-glucoside on glycated LDL-induced NADPH oxidase activation, mitochondrial dysfunction and cell viability in cultured vascular endothelial cells. Int J Mol Sci. 2012; 13:15867-15880.
40. Yang Z, Mo X, Gong Q, et al. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose. Apoptosis. 2008;13: 1331-1343.
41. Frezza C, Cipolat S, Martins de Brito O, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006; 126:177-189.
42. Merkwirth C, Dargazanli S, Tatsuta T, et al. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev. 2008;22:476-488.
43. Zhang Z, Lapolla SM, Annis MG, et al. Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax. J Biol Chem. 2004;279:43920-43928.
44. Tan C, Dlugosz PJ, Peng J, et al. Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J Biol Chem. 2006;281:14764-14775.
45. Schleicher M, Shepherd BR, Suarez Y, et al. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol. 2008;180:101-112.
46. Miyauchi H, Minamino T, Tateno K, et al. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004;23:212-220.
47. Wang Q, Leader A, Tsang BK. Inhibitory roles of prohibitin and chemerin in FSH-induced rat granulosa cell steroidogenesis. Endocrinology. 2013;154:956-967.
48. Wang Q, Leader A, Tsang BK. Follicular stage-dependent regulation of apoptosis and steroidogenesis by prohibitin in rat granulosa cells. J Ovarian Res. 2013;6:23.